参考文献/References:
[1]Treinys R,Jurevicius J.L-type Ca2+ channels in the heart:structure and regulation[J].Medicina (Kaunas),2008,44(7):491-499.
[2]Liu X,Shi S,Yang H,et al.The activation of N-methyl-d-aspartate receptors downregulates transient outward potassium and L-type calcium currents in rat models of depression[J].Am J Physiol Cell Physiol,2017,313(2):C187-C196.
[3]Hu Z,Liang MC,Soong TW. Alternative splicing of L-type CaV1.2 calcium channels: implications in cardiovascular diseases[J].Genes (Basel),2017,8(12). pii: E344.
[4]Wilson D,Ermentrout B,Němec J,et al..A model of cardiac ryanodine receptor gating predicts experimental Ca2+-dynamics and Ca2+-triggered arrhythmia in the long QT syndrome[J].Chaos,2017,27(9):093940.
[5]Tan WL,Xu M,Liu Z,et al.HOTAIR inhibited intracellular Ca2+ via regulation of CaV1.2 channel in human cardiomyocytes[J].Cell Mol Biol (Noisy-le-grand),2015,61(3):79-83.
[6]Yang L,Liu G,Zakharov SI,et al.Protein kinase G phosphorylates CaV1.2 alpha1c and beta2 subunits[J].Circ Res ,2007,101(5):465-474.
[7]Qian H,Patriarchi T,Price JL,et al.Phosphorylation of Ser1928 mediates the enhanced activity of the L-type Ca2+ channel CaV1.2 by the β2-adrenergic receptor in neurons[J].Sci Signal ,2017,10(463).pii: eaaf9659.
[8]Lyu L,Gao Q,Xu J,et al.A new interaction between proximal and distal C-terminus of CaV1.2 channels[J].J Pharmacol Sci ,2017,133(4):240-246.
[9]Shuja Z,Colecraft HM.Regulation of microdomain voltage-gated L-type calcium channels in cardiac health and disease[J].Curr Opin Physiol,2018,2:13-18.
[10]Raifman TK,Kumar P,Haase H,et al.Protein kinase C enhances plasma membrane expression of cardiac L-type calcium channel,CaV1.2 [J].Channels (Austin) ,2017,11(6):604-615.[11]Qi XY,Yeh YH,Xiao L,et al.Cellular signaling underlying atrial tachycardia remodeling of L-type calcium current[J].Circ Res,2008,103(8):845-854.
[12]Minobe E,Mori MX,Kameyama M.Calmodulin and ATP support activity of the CaV1.2 channel through dynamic interactions with the channel[J].J Physiol,2017,595(8):2465-2477.[13]Iwasaki YK,Nishida K,Kato T,et al.Atrial fibrillation pathophysiology:implications formanagement[J].Circulation,2011,124(20):2264-2274.
[14]Dinanian S,Boixel C,Juin C,et al.Downregulation of the calcium current in human right atrial myocytes from patients in sinus rhythm but with a high risk of atrial fibrillation[J].Eur Heart J,2008,29(9):1190-1197.
[15]Drum BM,Dixon?RE,Yuan?C,et al.Cellular mechanisms of ventricular arrhythmias in a mouse model of Timothy syndrome (long QT syndrome 8)[J].J Mol Cell Cardiol,2014,66:63-71. [16]Dufendach?KA,Timothy?K,Ackerman?MJ,et?al.Clinical?Outcomes?and?Modes?of?Death?in?Timothy Syndrome: A Multicenter International Study of a Rare Disorder[J].JACC Clin Electrophysiol,2018,4(4):459-466.
[17]Berne?P,Brugada?J.Brugada syndrome 2012[J].Circ?J,2012,76(7):1563-1571.
[18]Brugada R,Campuzano O,Sarquella-Brugada G,et al.Brugada ?syndrome[J].Methodist Debakey Cardiovasc?J,2014,10(1):25-28.
[19]Yang Q,Qi X,Dang Y,et al.Effects of atorvastatin on atrial remodeling in a rabbit model of atrial fibrillation produced by rapid atrial pacing[J].BMC Cardiovasc?Disord,2016,16(1):142.
[20]Pan Y,Li B,Wang J,et al.Rosuvastatin alleviates type 2 diabetic atrial structural and calcium channel remodeling[J].J Cardiovasc?Pharmacol,2016,67(1):57-67.
[21]Liu SH,Hsiao YW,Chong E,et al.Rhodiola inhibits atrial arrhythmogenesis in a heart failure model[J].J Cardiovasc?Electrophysiol,2016,27(9):1093-1101.
[22]Yuan Y,Zhao J,Gong Y,et al.Autophagy exacerbates electrical remodeling in atrial fibrillation by ubiquitin-dependent degradation of L-type calcium channel[J].Cell Death Dis,2018,9(9):873.
[23]Farghaly HSM,Ashry IEM,Hareedy MS.High doses of digoxin increase the myocardial nuclear factor-κB and CaV1.2?channels in healthy mice.A possible mechanism of digitalis toxicity[J].Biomed Pharmacother,2018,105:533-539.
[24]Nakatani Y,Nishida K,Sakabe M,et al.Tranilast prevents atrial remodeling and development of atrial fibrillation in a canine model of atrial tachycardia and left ventricular dysfunction[J].J Am Coll?Cardiol,2013,61(5):582-588.
[25]Sheng X,Nakada T,Kobayashi M,et?al.Two?mechanistically distinct effects of dihydropyridine?nifedipine?on?CaV1.2?L-type Ca2+ channels?revealed?by?Timothy?syndrome?mutation[J].Eur J Pharmacol,2012,685(1-3):15-23.
[26]Song L,Park SE,Isseroff?Y,et?al.Inhibition of CDK5 alleviates the cardiac phenotypes in Timothy syndrome[J].Stem Cell?Reports,2017,9(1):50-57.
[27]Brodie OT,Michowitz?Y,Belhassen?B.Pharmacological therapy in Brugada syndrome[J].A rrhythm Electrophysiol?Rev,2018,7(2):135-142.
[28]Saha SA,Krishnan K,Madias C,et al.Combined right ventricular outflow tract epicardial and endocardial late potential ablation for treatment of Brugada storm: a case report and review of the literature[J].Cardiol?Ther,2016,5(2):229-243.
[29]Liszt T,Koncz I,Antzelevitch C.Cellular mechanisms underlying the effects of milrinone and cilostazol to suppress arrhythmogenesis associated with Brugada syndrome[J].Heart Rhythm,2013,10(11):1720-1727.
[30]Minoura Y,Panama BK,Nesterenko VV,et al.Effect of Wenxin Keli and quinidine to suppress arrhythmogenesis in an experimental model of Brugada syndrome[J].Heart Rhythm,2013,10(7):1054-1062.